Overall Goals and Objectives
1. Identify transdifferentiation as an important source of activated myofibroblasts in SSc and related fibrotic conditions.
2. Understand the implications of this phenomenon in lung fibrosis models.
3. Identify this phenomenon as possible target for future therapy for lung fibrotic diseases.
Presentation: 59 minutes
Recommended CitationMendoza, MD, Fabian A., "Role of the Endothelial-Mesenchymal Transdifferentiation in Pulmonary Fibrosis and Related Fibrotic Processes" (2012). Division of Pulmonary and Critical Care Medicine Presentations and Grand Rounds. Presentation 46.